Podcast Episode Details
Back to Podcast Episodes
How can India’s pharma companies survive under Trump’s uncertainty?
In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.
Published on 5 months ago